Juvenile Diabetes Research Foundation (JDRF): Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights

JDRF International, in partnership with the Lupus Research Alliance and the National Multiple Sclerosis Society, is soliciting Letters of Intent (LOI) from investigators across autoimmune (and other relevant) fields to advance the understanding of autoimmunity and to obtain more specific insights into commonalities and differences of immune pathways that govern these pathogenic processes. The incomplete knowledge of immune networks, pathways, disease pathogenesis and heterogeneity across multiple autoimmune diseases remains a challenge towards achieving optimal therapies to effectively treat all subjects in a given indication.

The purpose of this call is to invite innovative ideas that address needs across multiple autoimmune diseases in novel ways that may allow us to make faster progress together. Applications must address one or more of the following autoimmune diseases: Type 1 Diabetes (T1D), Systemic Lupus Erythematosus (SLE) and Multiple Sclerosis (MS).

Funding & Duration

Strategic Research Agreements (SRA): proposed project budgets should not exceed USD $750,000 (approx. AUD $1.1M) for up to three years.

Pilot & Feasibility (PNF) projects: should be limited to a total proposed budget of USD $200,000 (approx. AUD $286,000) for up to two years.


View the Program Guidelines (PDF) for eligibility details.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.